Diffusion- and perfusion-weighted MRI radiomics model may predict isocitrate dehydrogenase (IDH) mutation and tumor aggressiveness in diffuse lower grade glioma
暂无分享,去创建一个
Ho Sung Kim | Seo Young Park | S. Park | H. Kim | J. E. Park | Jeong Hoon Kim | S. Nam | Minjae Kim | Ji Eun Park | Soo Jung Nam | Minjae Kim | So Yeong Jung | Yeongheun Jo | J. Kim | Y. Jo
[1] G. Johnson,et al. Relative cerebral blood volume measurements of low-grade gliomas predict patient outcome in a multi-institution setting. , 2010, European journal of radiology.
[2] Baojuan Li,et al. Radiomics Strategy for Molecular Subtype Stratification of Lower‐Grade Glioma: Detecting IDH and TP53 Mutations Based on Multimodal MRI , 2018, Journal of magnetic resonance imaging : JMRI.
[3] Tin Kam Ho,et al. The Random Subspace Method for Constructing Decision Forests , 1998, IEEE Trans. Pattern Anal. Mach. Intell..
[4] Dafna Ben-Bashat,et al. MRI radiomics analysis of molecular alterations in low-grade gliomas , 2018, International Journal of Computer Assisted Radiology and Surgery.
[5] Sohil H. Patel,et al. T2–FLAIR Mismatch, an Imaging Biomarker for IDH and 1p/19q Status in Lower-grade Gliomas: A TCGA/TCIA Project , 2017, Clinical Cancer Research.
[6] T. Cloughesy,et al. NIMG-24HIGH SPATIOTEMPORAL DYNAMIC SUSCEPTIBILITY CONTRAST (DSC) PERFUSION MRI USING MULTIBAND ECHOPLANAR IMAGING (MB-EPI) , 2015 .
[7] Qiang Tian,et al. Radiomics strategy for glioma grading using texture features from multiparametric MRI , 2018, Journal of magnetic resonance imaging : JMRI.
[8] Glyn Johnson,et al. Comparison of cerebral blood volume and vascular permeability from dynamic susceptibility contrast-enhanced perfusion MR imaging with glioma grade. , 2004, AJNR. American journal of neuroradiology.
[9] How Far Are We from Using Radiomics Assessment of Gliomas in Clinical Practice? , 2018, Radiology.
[10] Hans Kristian Bø,et al. Quantitative texture analysis in the prediction of IDH status in low-grade gliomas , 2018, Clinical Neurology and Neurosurgery.
[11] Wei Cao,et al. Deep Learning based Radiomics (DLR) and its usage in noninvasive IDH1 prediction for low grade glioma , 2017, Scientific Reports.
[12] M Takahashi,et al. Correlation of MR imaging-determined cerebral blood volume maps with histologic and angiographic determination of vascularity of gliomas. , 1998, AJR. American journal of roentgenology.
[13] Yi-bin Xi,et al. Noninvasively evaluating the grading and IDH1 mutation status of diffuse gliomas by three-dimensional pseudo-continuous arterial spin labeling and diffusion-weighted imaging , 2018, Neuroradiology.
[14] Marion Smits,et al. Consensus recommendations for a standardized Brain Tumor Imaging Protocol in clinical trials. , 2015, Neuro-oncology.
[15] G. Reifenberger,et al. The 2016 World Health Organization Classification of Tumors of the Central Nervous System: a summary , 2016, Acta Neuropathologica.
[16] Susan M. Chang,et al. Evaluation of MR markers that predict survival in patients with newly diagnosed GBM prior to adjuvant therapy , 2008, Journal of Neuro-Oncology.
[17] Andre Dekker,et al. Radiomics: the process and the challenges. , 2012, Magnetic resonance imaging.
[18] Benjamin M. Ellingson,et al. Radiogenomics and Imaging Phenotypes in Glioblastoma: Novel Observations and Correlation with Molecular Characteristics , 2014, Current Neurology and Neuroscience Reports.
[19] E. Shaw,et al. Phase III trial of chemoradiotherapy for anaplastic oligodendroglioma: long-term results of RTOG 9402. , 2013, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[20] Arno Klein,et al. A reproducible evaluation of ANTs similarity metric performance in brain image registration , 2011, NeuroImage.
[21] A. Bjørnerud,et al. Histogram Analysis of MR Imaging–Derived Cerebral Blood Volume Maps: Combined Glioma Grading and Identification of Low-Grade Oligodendroglial Subtypes , 2008, American Journal of Neuroradiology.
[22] Toshinori Hirai,et al. Usefulness of diffusion‐weighted MRI with echo‐planar technique in the evaluation of cellularity in gliomas , 1999, Journal of magnetic resonance imaging : JMRI.
[23] Yang Yang,et al. Optimizing Texture Retrieving Model for Multimodal MR Image‐Based Support Vector Machine for Classifying Glioma , 2019, Journal of magnetic resonance imaging : JMRI.
[24] Jong-Hee Chang,et al. Whole-Tumor Histogram and Texture Analyses of DTI for Evaluation of IDH1-Mutation and 1p/19q-Codeletion Status in World Health Organization Grade II Gliomas , 2018, American Journal of Neuroradiology.
[25] G. Reifenberger,et al. European Association for Neuro-Oncology (EANO) guideline on the diagnosis and treatment of adult astrocytic and oligodendroglial gliomas. , 2017, The Lancet. Oncology.
[26] C. Crainiceanu,et al. Statistical normalization techniques for magnetic resonance imaging , 2014, NeuroImage: Clinical.
[27] P. Lambin,et al. Radiomics: the bridge between medical imaging and personalized medicine , 2017, Nature Reviews Clinical Oncology.
[28] Jason Weston,et al. Gene Selection for Cancer Classification using Support Vector Machines , 2002, Machine Learning.
[29] A. Lagares,et al. The Added Value of Apparent Diffusion Coefficient to Cerebral Blood Volume in the Preoperative Grading of Diffuse Gliomas , 2012, American Journal of Neuroradiology.
[30] Patrick Granton,et al. Radiomics: extracting more information from medical images using advanced feature analysis. , 2012, European journal of cancer.
[31] Chia-Feng Lu,et al. Machine Learning–Based Radiomics for Molecular Subtyping of Gliomas , 2018, Clinical Cancer Research.
[32] S. Y. Kim,et al. A Prospective Study on the Added Value of Pulsed Arterial Spin-Labeling and Apparent Diffusion Coefficients in the Grading of Gliomas , 2007, American Journal of Neuroradiology.
[33] Mitchel S Berger,et al. Regional variation in histopathologic features of tumor specimens from treatment-naive glioblastoma correlates with anatomic and physiologic MR Imaging. , 2012, Neuro-oncology.
[34] S. Heiland,et al. IDH mutation status is associated with a distinct hypoxia/angiogenesis transcriptome signature which is non-invasively predictable with rCBV imaging in human glioma , 2015, Scientific Reports.
[35] Inas S. Khayal,et al. Relationship of pre-surgery metabolic and physiological MR imaging parameters to survival for patients with untreated GBM , 2009, Journal of Neuro-Oncology.
[36] D. Oldridge,et al. MRI features predict survival and molecular markers in diffuse lower-grade gliomas , 2017, Neuro-oncology.
[37] Glyn Johnson,et al. Glioma grading: sensitivity, specificity, and predictive values of perfusion MR imaging and proton MR spectroscopic imaging compared with conventional MR imaging. , 2003, AJNR. American journal of neuroradiology.
[38] Sung Tae Kim,et al. Diffusion radiomics as a diagnostic model for atypical manifestation of primary central nervous system lymphoma: development and multicenter external validation , 2018, Neuro-oncology.
[39] Usha Sinha,et al. Relationships Between Choline Magnetic Resonance Spectroscopy, Apparent Diffusion Coefficient and Quantitative Histopathology in Human Glioma , 2000, Journal of Neuro-Oncology.
[40] Jie Tian,et al. Grading of Gliomas by Using Radiomic Features on Multiple Magnetic Resonance Imaging (MRI) Sequences , 2017, Medical science monitor : international medical journal of experimental and clinical research.
[41] Winand N M Dinjens,et al. Adjuvant procarbazine, lomustine, and vincristine chemotherapy in newly diagnosed anaplastic oligodendroglioma: long-term follow-up of EORTC brain tumor group study 26951. , 2013, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[42] Mauricio Castillo,et al. Cerebral blood volume measurements and proton MR spectroscopy in grading of oligodendroglial tumors. , 2007, AJR. American journal of roentgenology.
[43] M. J. van den Bent,et al. The T2-FLAIR mismatch sign as an imaging marker for non-enhancing IDH-mutant, 1p/19q-intact lower-grade glioma: a validation study , 2018, Neuro-oncology.
[44] M. Götz,et al. Radiomic Profiling of Glioblastoma: Identifying an Imaging Predictor of Patient Survival with Improved Performance over Established Clinical and Radiologic Risk Models. , 2016, Radiology.
[45] Guang Li,et al. Gene signatures based on therapy responsiveness provide guidance for combined radiotherapy and chemotherapy for lower grade glioma , 2020, Journal of cellular and molecular medicine.
[46] Gary S Collins,et al. Transparent Reporting of a multivariable prediction model for Individual Prognosis Or Diagnosis (TRIPOD): Explanation and Elaboration , 2015, Annals of Internal Medicine.
[47] P. Lambin,et al. Decoding tumour phenotype by noninvasive imaging using a quantitative radiomics approach , 2014, Nature Communications.
[48] Tarik Tihan,et al. MRI Features and IDH Mutational Status of Grade II Diffuse Gliomas: Impact on Diagnosis and Prognosis. , 2017, AJR. American journal of roentgenology.
[49] L. Lin,et al. A concordance correlation coefficient to evaluate reproducibility. , 1989, Biometrics.